Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

POINT Biopharma Global Inc. (PNT) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $5.83 Metrics
OS: 105.8 M 22 % ROE
Market cap: $617 M
Net cash: $446 M $4.22 per share
EV: $170 M

 
TTM Valuation
EBITDA
EBIT
EPS $1.04 5.6 x P/E

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
Revenues226.60.00.0
Cost of goods sold0.00.00.0
Gross profit226.60.00.0
            Gross margin100.0%  
Research and development82.133.59.1
General and administrative19.012.04.0
EBIT125.5-45.5-13.1
            EBIT margin55.4%  
Pre-tax income129.6-45.6-13.3
Income taxes31.30.30.1
            Tax rate24.1%  
Net income98.3-45.9-13.4
            Net margin43.4%  
 
Diluted EPS$1.02($0.62)($0.34)
Shares outstanding (diluted)96.073.938.9
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy